EQS-News: Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer
Hennigsdorf/Berlin (Germany), February 1, 2023 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Stephan Witte as Chief Medical Officer (CMO) of Adrenomed.
- Hennigsdorf/Berlin (Germany), February 1, 2023 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Stephan Witte as Chief Medical Officer (CMO) of Adrenomed.
- Dr. Stephan Witte is a drug development professional with over 20 years of experience in clinical development and a strong disease expertise in sepsis and septic shock.
- “I am delighted to welcome Stephan to the Adrenomed team.
- Here, Stephan Witte was responsible for the clinical development and regulatory interactions for Inotrem’s lead compound in the indication of septic shock.